Chartrand, Dominic J. https://orcid.org/0000-0002-2218-9559
Murphy-Després, Adrien https://orcid.org/0000-0003-4137-2807
Alméras, Natalie https://orcid.org/0000-0002-4660-2299
Lemieux, Isabelle https://orcid.org/0000-0003-4723-9986
Larose, Eric https://orcid.org/0000-0002-2263-7390
Després, Jean-Pierre https://orcid.org/0000-0002-5193-583X
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP-114820, FDN-167278)
Article History
Accepted: 17 November 2021
First Online: 2 March 2022
Declarations
:
: D. J. Chartrand is a recipient of PhD scholarships from the Fonds de recherche du Québec-Santé (FRQS) and from the Canadian Institutes of Health Research (CIHR).E. Larose is a FRQS Senior Clinical Research Scholar and holds the Chair of Research and Innovation in Cardiovascular Imaging at Université Laval. E. Larose reports grants from FRQS and grants from Fondation IUCPQ, during the conduct of the study.J.-P. Després is the Scientific Director of the International Chair on Cardiometabolic Risk at Université Laval. The CMCV study was supported by the CIHR (MOP-114820) and is a component of a research program supported by a Foundation Scheme Grant (FDN-167278) from the CIHR awarded to J.-P. Després. J.-P. Després also reports grants from Fondation IUCPQ, outside the submitted work.N. Alméras reports grants from Fondation IUCPQ, grants from Fondation IUCPQ, outside the submitted work.The other authors declare that they have no conflict of interest.
: All reported studies/experiments with human subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). The local institutional review board approved the CMCV study (2012–1747, 20769), and participants provided their written informed consent.